Meeting of the Parliament

Time for Reflection Rev Julie Moody, Minister, Milton of Campsie Parish Church followed by Topical Questions Jamie Greene S6T-02834 1. To ask the Scottish Government what its response is to reports that the former chief executive of CalMac received a severance package exceeding £170,000, including whether this complied with the severance provisions set out in the Scottish Public Finance Manual. Paul O'Kane S6T-02831 2. To ask the Scottish Government what its response is to reports of a postcode lottery for classroom supplies and that some schools have only 93p per child per week for basic classroom supplies. followed by Ministerial Statement: Scottish Budget 2026-27 followed by Stage 1 Debate: Crofting and Scottish Land Court Bill Jim Fairlie S6M-20388 That the Parliament agrees to the general principles of the Crofting and Scottish Land Court Bill. Further details available for S6M-20388 followed by Financial Resolution: Crofting and Scottish Land Court Bill Shona Robison S6M-20169 That the Parliament, for the purposes of any Act of the Scottish Parliament resulting from the Crofting and Scottish Land Court Bill, agrees to any expenditure of a kind referred to in Rule (a) 9.12.3 and (b) 9.12.3A of the Parliament’s Standing Orders arising in consequence of the Act. Further details available for S6M-20169 followed by Decision Time followed by Members’ Business: Improving Support and Treatment for People Living with PKU in Scotland Fulton MacGregor S6M-20160 That the Parliament recognises that phenylketonuria (PKU) is a rare, lifelong metabolic disorder in which the body is unable to process the amino acid phenylalanine, leading to a risk of severe and irreversible neurological damage without strict dietary management; acknowledges the significant daily burden placed on individuals and families living with PKU, including the need for constant monitoring and the exclusion of most everyday foods; notes the recent drop-in event hosted in the Scottish Parliament, which highlighted lived experience and current challenges in accessing treatment and support; further notes ongoing UK trials of a home blood phenylalanine monitoring device and the emerging treatment, sepiapterin, both of which offer the potential to improve quality of life; recognises the work of the National Society for Phenylketonuria (NSPKU) in advocating for improved care and access to treatment, and notes the calls on the Scottish Government and NHS Scotland to consider how services for people with PKU can be strengthened to support better long-term outcomes, including in the Coatbridge and Chryston constituency. Further details available for S6M-20160